Search

Abhishek Sarma

Examiner (ID: 5655, Phone: (571)272-9887 , Office: P/2697 )

Most Active Art Unit
2622
Art Unit(s)
2621, 2622, 2697
Total Applications
894
Issued Applications
742
Pending Applications
77
Abandoned Applications
104

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5136469 [patent_doc_number] => 20070078098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Anti-hypercholesterolemic compounds' [patent_app_type] => utility [patent_app_number] => 11/542966 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13039 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078098.pdf [firstpage_image] =>[orig_patent_app_number] => 11542966 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/542966
Anti-hypercholesterolemic compounds Oct 3, 2006 Issued
Array ( [id] => 4971994 [patent_doc_number] => 20070111997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Triazolopyrimidines and related analogs as HSP90-inhibitors' [patent_app_type] => utility [patent_app_number] => 11/537017 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25431 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111997.pdf [firstpage_image] =>[orig_patent_app_number] => 11537017 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/537017
Triazolopyrimidines and related analogs as HSP90-inhibitors Sep 28, 2006 Abandoned
Array ( [id] => 4971993 [patent_doc_number] => 20070111996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Pyrazolopyrimidines and related analogs as HSP90-inhibitors' [patent_app_type] => utility [patent_app_number] => 11/537002 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35783 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 59 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111996.pdf [firstpage_image] =>[orig_patent_app_number] => 11537002 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/537002
Pyrazolopyrimidines and related analogs as HSP90-inhibitors Sep 28, 2006 Abandoned
Array ( [id] => 5564693 [patent_doc_number] => 20090137546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Anti-Hypercholesterolemic Compounds' [patent_app_type] => utility [patent_app_number] => 11/992990 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13035 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137546.pdf [firstpage_image] =>[orig_patent_app_number] => 11992990 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/992990
Anti-Hypercholesterolemic Compounds Sep 28, 2006 Abandoned
Array ( [id] => 5285541 [patent_doc_number] => 20090099216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'NOVEL ADENINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/067781 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18415 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099216.pdf [firstpage_image] =>[orig_patent_app_number] => 12067781 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067781
NOVEL ADENINE COMPOUND Sep 21, 2006 Abandoned
Array ( [id] => 5586010 [patent_doc_number] => 20090105212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'NOVEL ADENINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/067651 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31215 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105212.pdf [firstpage_image] =>[orig_patent_app_number] => 12067651 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067651
NOVEL ADENINE COMPOUND Sep 21, 2006 Abandoned
Array ( [id] => 5380314 [patent_doc_number] => 20090192153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'NOVEL ADENINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/067780 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35427 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192153.pdf [firstpage_image] =>[orig_patent_app_number] => 12067780 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067780
NOVEL ADENINE COMPOUND Sep 20, 2006 Abandoned
Array ( [id] => 4860390 [patent_doc_number] => 20080269240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Novel Adenine Compound' [patent_app_type] => utility [patent_app_number] => 12/067446 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47900 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269240.pdf [firstpage_image] =>[orig_patent_app_number] => 12067446 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067446
Novel Adenine Compound Sep 20, 2006 Abandoned
Array ( [id] => 5290993 [patent_doc_number] => 20090023723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Purinone derivatives for treating neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 11/534096 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17867 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023723.pdf [firstpage_image] =>[orig_patent_app_number] => 11534096 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/534096
Purinone derivatives for treating neurodegenerative diseases Sep 20, 2006 Abandoned
Array ( [id] => 5509125 [patent_doc_number] => 20090082332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL OR ALLERGIC DISEASES AND CANCERS' [patent_app_type] => utility [patent_app_number] => 12/067536 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16395 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082332.pdf [firstpage_image] =>[orig_patent_app_number] => 12067536 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067536
PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL OR ALLERGIC DISEASES AND CANCERS Sep 19, 2006 Abandoned
Array ( [id] => 5265578 [patent_doc_number] => 20090118263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Novel Adenine Compound' [patent_app_type] => utility [patent_app_number] => 12/067649 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39505 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118263.pdf [firstpage_image] =>[orig_patent_app_number] => 12067649 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067649
Novel Adenine Compound Sep 19, 2006 Abandoned
Array ( [id] => 560719 [patent_doc_number] => 07470786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-30 [patent_title] => 'Method for manufacture of ceftriaxone sodium' [patent_app_type] => utility [patent_app_number] => 11/532469 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15004 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470786.pdf [firstpage_image] =>[orig_patent_app_number] => 11532469 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/532469
Method for manufacture of ceftriaxone sodium Sep 14, 2006 Issued
Array ( [id] => 7693769 [patent_doc_number] => 20070015917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Method For Manufacture of Ceftriaxone Sodium' [patent_app_type] => utility [patent_app_number] => 11/532485 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15214 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015917.pdf [firstpage_image] =>[orig_patent_app_number] => 11532485 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/532485
Method For Manufacture of Ceftriaxone Sodium Sep 14, 2006 Abandoned
Array ( [id] => 5496615 [patent_doc_number] => 20090264643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Process for The Preparation of Beta-Lactam Antibiotic' [patent_app_type] => utility [patent_app_number] => 11/991624 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5088 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264643.pdf [firstpage_image] =>[orig_patent_app_number] => 11991624 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/991624
Process for the preparation of beta-lactam antibiotic meropenem trihydrate Sep 14, 2006 Issued
Array ( [id] => 5160439 [patent_doc_number] => 20070173483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Pyrrolopyrimidines and Related Analogs as HSP90-Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/531218 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46442 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173483.pdf [firstpage_image] =>[orig_patent_app_number] => 11531218 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/531218
Pyrrolopyrimidines and Related Analogs as HSP90-Inhibitors Sep 11, 2006 Abandoned
Array ( [id] => 5576038 [patent_doc_number] => 20090143400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'PURINE DERIVATIVES HAVING IMMUNO-MODULATING PROPERTIES' [patent_app_type] => utility [patent_app_number] => 12/066952 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10292 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143400.pdf [firstpage_image] =>[orig_patent_app_number] => 12066952 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/066952
PURINE DERIVATIVES HAVING IMMUNO-MODULATING PROPERTIES Sep 11, 2006 Abandoned
Array ( [id] => 5101802 [patent_doc_number] => 20070185064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => '2-Aminopurine Analogs Having HSP90-Inhibiting Activity' [patent_app_type] => utility [patent_app_number] => 11/531221 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48111 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185064.pdf [firstpage_image] =>[orig_patent_app_number] => 11531221 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/531221
2-Aminopurine Analogs Having HSP90-Inhibiting Activity Sep 11, 2006 Abandoned
Array ( [id] => 4705181 [patent_doc_number] => 20080064705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation' [patent_app_type] => utility [patent_app_number] => 11/520174 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6913 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064705.pdf [firstpage_image] =>[orig_patent_app_number] => 11520174 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/520174
Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation Sep 11, 2006 Abandoned
Array ( [id] => 5016636 [patent_doc_number] => 20070259845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe' [patent_app_type] => utility [patent_app_number] => 11/517704 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10223 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259845.pdf [firstpage_image] =>[orig_patent_app_number] => 11517704 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/517704
Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe Sep 7, 2006 Abandoned
Array ( [id] => 5063664 [patent_doc_number] => 20070225304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 11/470347 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8552 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225304.pdf [firstpage_image] =>[orig_patent_app_number] => 11470347 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/470347
AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES Sep 5, 2006 Abandoned
Menu